P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial
Aviv Pudipeddi(The University of Sydney), Rupert W. Leong(The University of Sydney), Ramesh Paramsothy(Liverpool Hospital), M Ward(The Alfred Hospital), Peter De Cruz(The University of Melbourne), C Haifer(UNSW Sydney), D Redmond(Concord Repatriation General Hospital), Simon Ghaly(UNSW Sydney), Susan J. Connor(Liverpool Hospital), Melissa Kermeen(Concord Repatriation General Hospital), Viraj C. Kariyawasam(Concord Repatriation General Hospital), Jakob Begun(Translational Research Institute), Yoon‐Kyo An(Mater Hospital), Webber Chan(Concord Repatriation General Hospital), Crispin Corte(Royal Prince Alfred Hospital), Caroline Fung, Sudarshan Paramsothy(University of Chicago), P Dhanji(Concord Repatriation General Hospital), Fadi H. Mourad(Concord Repatriation General Hospital)
Cited by 0
Related Papers
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
|Journal of Crohn s and Colitis|2017|425
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
|PLoS Genetics|2013|217
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
|Journal of Crohn s and Colitis|2013|114
Defined microbiota transplant restores Th17/RORγt <sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
|Proceedings of the National Academy of Sciences|2020|107
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
|Journal of Crohn s and Colitis|2020|102